{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:15:20Z","timestamp":1791292520444,"version":"4.1.0"},"reference-count":135,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.neuropharm.2014.04.009","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T01:38:59Z","timestamp":1398303539000},"page":"137-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Neurodegenerative changes are prevented by Erythropoietin in the pmn model of motoneuron degeneration"],"prefix":"10.1016","volume":"83","author":[{"given":"Marta","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Fe","family":"Mart\u00ednez-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Monle\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva","family":"Gim\u00e9nez y Ribotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2014.04.009_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tins.2010.12.001","article-title":"Astrocyte-neuron metabolic relationships: for better and for worse","volume":"34","author":"Allaman","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/039463200501800104","article-title":"MAPK activation via 5-hydroxytryptamine 1A receptor is involved in the neuroprotective effects of xaliproden","volume":"18","author":"Appert-Collin","year":"2005","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/039463200401700207","article-title":"Quantification of neurotrophin mRNA expression in PMN mouse: modulation by xaliproden","volume":"17","author":"Appert-Collin","year":"2004","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0306-4522(01)00181-6","article-title":"Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes","volume":"105","author":"Aronica","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.brainresrev.2004.05.003","article-title":"A\u00a0role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis","volume":"47","author":"Barbeito","year":"2004","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.neuro.2005.01.016","article-title":"Erythropoietin: a novel neuroprotective cytokine","volume":"26","author":"Bartesaghi","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-3565(24)29662-2","article-title":"A\u00a0peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice","volume":"296","author":"Beni-Adani","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroscience.2006.11.062","article-title":"Is lactate food for neurons? Comparison of monocarboxylate transporter subtypes in brain and muscle","volume":"145","author":"Bergersen","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0006-8993(91)91680-Y","article-title":"Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord","volume":"566","author":"Bertel","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib10","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/jcbfm.2009.97","article-title":"Neuroprotective role of lactate after cerebral ischemia","volume":"29","author":"Berthet","year":"2009","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib11","first-page":"112P","article-title":"Further evidence for the possible coexistence of 5-hydroxytryptamine and substance P in medullary raphe neurones of rat brain","volume":"66","author":"Bjorklund","year":"1979","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib12","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1523\/JNEUROSCI.0805-04.2004","article-title":"Dual-gene, dual-cell type therapy against an excitotoxic insult by bolstering neuroenergetics","volume":"24","author":"Bliss","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/archneur.55.7.931","article-title":"Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements","volume":"55","author":"Block","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","article-title":"ALS: a disease of motor neurons and their nonneuronal neighbors","volume":"52","author":"Boillee","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1083\/jcb.200208001","article-title":"Missense mutation in the tubulin-specific chaperone E (Tbce) gene in the mouse mutant progressive motor neuronopathy, a model of human motoneuron disease","volume":"159","author":"Bommel","year":"2002","journal-title":"J.\u00a0Cell. Biol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neulet.2006.06.011","article-title":"Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases","volume":"404","author":"Brettschneider","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2119\/molmed.2011.00414","article-title":"The receptor that tames the innate immune response","volume":"18","author":"Brines","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib18","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","article-title":"Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury","volume":"97","author":"Brines","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90346-1","article-title":"Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice","volume":"80","author":"Brown","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/geno.1995.1223","article-title":"The mouse mutation progressive motor neuronopathy (pmn) maps to chromosome 13","volume":"29","author":"Brunialti","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0306-4522(92)90504-U","article-title":"Calcitonin gene-related peptide in rat spinal cord motoneurons: subcellular distribution and changes induced by axotomy","volume":"48","author":"Caldero","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1083\/jcb.135.3.701","article-title":"Delivery of newly synthesized tubulin to rapidly growing distal axons of sympathetic neurons in compartmented cultures","volume":"135","author":"Campenot","year":"1996","journal-title":"J.\u00a0Cell. Biol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0028-3908(03)00042-X","article-title":"Block of slow axonal transport and axonal growth by brefeldin A in compartmented cultures of rat sympathetic neurons","volume":"44","author":"Campenot","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib24","doi-asserted-by":"crossref","first-page":"RC148","DOI":"10.1523\/JNEUROSCI.21-11-j0002.2001","article-title":"Increased expression of neuronal nitric oxide synthase spliced variants in reactive astrocytes of amyotrophic lateral sclerosis human spinal cord","volume":"21","author":"Catania","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib25","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1073\/pnas.042693799","article-title":"Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury","volume":"99","author":"Celik","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0168-0102(89)90033-3","article-title":"Coexistence of varying combinations of neuropeptides with 5-hydroxytryptamine in neurons of the raphe pallidus et obscurus projecting to the spinal cord","volume":"7","author":"Chiba","year":"1989","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/nbm.1145","article-title":"Application of MRS to mouse models of neurodegenerative illness","volume":"20","author":"Choi","year":"2007","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00004647-200205000-00001","article-title":"Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades","volume":"22","author":"Chong","year":"2002","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000017321","article-title":"N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction","volume":"20","author":"Clark","year":"1998","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/cc2897","article-title":"Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?","volume":"8","author":"Coleman","year":"2004","journal-title":"Crit. Care"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/375061a0","article-title":"Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"375","author":"Collard","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1471-4159.2001.00285.x","article-title":"N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury","volume":"77","author":"Demougeot","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-8993(96)00244-2","article-title":"Changes in receptor levels for thyrotropin releasing hormone, serotonin, and substance P in cervical spinal cord of Wobbler mouse: a quantitative autoradiography study during early and late stages of the motoneuron disease","volume":"725","author":"Deng","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.stem.2008.09.017","article-title":"Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation","volume":"3","author":"Di Giorgio","year":"2008","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib35","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nn1885","article-title":"Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model","volume":"10","author":"Di Giorgio","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0006-8993(89)90032-2","article-title":"Substance P receptors in the human spinal cord: decrease in amyotrophic lateral sclerosis","volume":"483","author":"Dietl","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib37","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.bjp.0701885","article-title":"The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouse","volume":"124","author":"Duong","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03402029","article-title":"Erythropoietin therapy for acute stroke is both safe and beneficial","volume":"8","author":"Ehrenreich","year":"2002","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.19-01-00001.1999","article-title":"Synthesis of beta-tubulin, actin, and other proteins in axons of sympathetic neurons in compartmented cultures","volume":"19","author":"Eng","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neuroscience.2007.11.058","article-title":"Low intensity exercise attenuates disease progression and stimulates cell proliferation in the spinal cord of a mouse model with progressive motor neuronopathy","volume":"152","author":"Ferrer-Alcon","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib41","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/WNR.0b013e3282ef6a11","article-title":"Grafted neural stem cells increase the life span and protect motoneurons in pmn mice","volume":"18","author":"Ferrer-Alcon","year":"2007","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-510X(00)00265-3","article-title":"Fragmentation of the Golgi apparatus of the anterior horn cells in patients with familial amyotrophic lateral sclerosis with SOD1 mutations and posterior column involvement","volume":"174","author":"Fujita","year":"2000","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1752-0509-5-162","article-title":"Astrocyte-neuron lactate shuttle may boost more ATP supply to the neuron under hypoxic conditions\u2013in silico study supported by in\u00a0vitro expression data","volume":"5","author":"Genc","year":"2011","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2202-5-17","article-title":"Asialoerythropoietin is not effective in the R6\/2 line of Huntington's disease mice","volume":"5","author":"Gil","year":"2004","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/01616412.1996.11740412","article-title":"Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis","volume":"18","author":"Giroud","year":"1996","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2006.01.019","article-title":"Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death","volume":"246","author":"Gonatas","year":"2006","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib47","first-page":"731","article-title":"Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis","volume":"140","author":"Gonatas","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V","article-title":"Proton NMR chemical shifts and coupling constants for brain metabolites","volume":"13","author":"Govindaraju","year":"2000","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib49","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.48.4.878","article-title":"Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy","volume":"48","author":"Gredal","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/17482960600783456","article-title":"Erythropoietin does not preserve motor neurons in a mouse model of familial ALS","volume":"8","author":"Grignaschi","year":"2007","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib51","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1073\/pnas.0812708106","article-title":"Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection","volume":"106","author":"Gunnarson","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib52","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jnr.490270305","article-title":"Rat facial motoneurons express increased levels of calcitonin gene-related peptide mRNA in response to axotomy","volume":"27","author":"Haas","year":"1990","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib53","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm0497-429","article-title":"Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors","volume":"3","author":"Haase","year":"1997","journal-title":"Nat. Med."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2014.04.009_bib54","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/S0022-510X(98)00207-X","article-title":"Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: therapeutic effects and mechanisms of action","volume":"160","author":"Haase","year":"1998","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib55","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.1083129","article-title":"Mutations in dynein link motor neuron degeneration to defects in retrograde transport","volume":"300","author":"Hafezparast","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib56","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#","article-title":"Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS","volume":"23","author":"Hall","year":"1998","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/glia.440040215","article-title":"Astroglia in CNS injury","volume":"4","author":"Hatten","year":"1991","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib58","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0306-4522(78)90017-9","article-title":"Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system","volume":"3","author":"Hokfelt","year":"1978","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib59","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0306-4522(88)90076-0","article-title":"Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus","volume":"24","author":"Holets","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib60","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J.\u00a0Cell. Biol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib61","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.expneurol.2011.09.015","article-title":"Therapeutic effects of PEGylated insulin-like growth factor I in the pmn mouse model of motoneuron disease","volume":"232","author":"Jablonka","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib62","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0166-2236(93)90090-9","article-title":"5-HT and motor control: a hypothesis","volume":"16","author":"Jacobs","year":"1993","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib63","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0959-4388(97)80141-9","article-title":"Serotonin and motor activity","volume":"7","author":"Jacobs","year":"1997","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0173(02)00187-X","article-title":"Activity of medullary serotonergic neurons in freely moving animals","volume":"40","author":"Jacobs","year":"2002","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jns.2007.01.057","article-title":"Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET","volume":"255","author":"Johansson","year":"2007","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib66","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/0306-4522(81)90028-2","article-title":"Immunohistochemical support for three putative transmitters in one neuron: coexistence of 5-hydroxytryptamine, substance P- and thyrotropin releasing hormone-like immunoreactivity in medullary neurons projecting to the spinal cord","volume":"6","author":"Johansson","year":"1981","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1203\/00006450-199801000-00007","article-title":"Erythropoietin and erythropoietin receptor in the developing human central nervous system","volume":"43","author":"Juul","year":"1998","journal-title":"Pediatr. Res."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2014.04.009_bib68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/17434470410019861","article-title":"ALS surrogate markers. MRS","volume":"5","author":"Kalra","year":"2004","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib69","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1097\/00001756-199806010-00016","article-title":"Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy","volume":"9","author":"Kalra","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib70","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archneur.63.8.1144","article-title":"Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy","volume":"63","author":"Kalra","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2011.06.059","article-title":"Erythropoietin decreases the excitatory neurotransmitter release probability and enhances synaptic plasticity in mice hippocampal slices","volume":"1410","author":"Kamal","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib72","doi-asserted-by":"crossref","first-page":"39469","DOI":"10.1074\/jbc.M105832200","article-title":"Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia","volume":"276","author":"Kawakami","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-510X(00)00423-8","article-title":"Riluzole prolongs survival and delays muscle strength deterioration in mice with progressive motor neuronopathy (pmn)","volume":"180","author":"Kennel","year":"2000","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/nbdi.1996.0014","article-title":"Electromyographical and motor performance studies in the pmn mouse model of neurodegenerative disease","volume":"3","author":"Kennel","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib75","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/j.1460-9568.2007.05471.x","article-title":"Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation","volume":"25","author":"Koh","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib76","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib77","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(02)00696-7","article-title":"Disruption of dynein\/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration","volume":"34","author":"LaMonte","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib78","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1098-1136(199912)28:3<215::AID-GLIA5>3.0.CO;2-C","article-title":"Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS)","volume":"28","author":"Levine","year":"1999","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib79","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1242\/jeb.02208","article-title":"Neuron-glia metabolic coupling and plasticity","volume":"209","author":"Magistretti","year":"2006","journal-title":"J.\u00a0Exp. Biol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib80","doi-asserted-by":"crossref","first-page":"875S","DOI":"10.3945\/ajcn.2009.27462CC","article-title":"Role of glutamate in neuron-glia metabolic coupling","volume":"90","author":"Magistretti","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib81","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.stem.2008.10.001","article-title":"Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells","volume":"3","author":"Marchetto","year":"2008","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib82","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ng1016","article-title":"A\u00a0missense mutation in Tbce causes progressive motor neuronopathy in mice","volume":"32","author":"Martin","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib83","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00586-008-0829-0","article-title":"Erythropoietin in spinal cord injury","volume":"18","author":"Matis","year":"2009","journal-title":"Eur. Spine J."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib84","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1073\/pnas.1533187100","article-title":"Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes","volume":"100","author":"Menet","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib85","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-2999(81)90020-0","article-title":"Substance P, but not TRH, modulates the 5-HT autoreceptor in ventral lumbar spinal cord","volume":"76","author":"Mitchell","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib86","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0306-4522(96)00306-5","article-title":"Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in\u00a0vitro glutamate-induced neuronal death","volume":"76","author":"Morishita","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib87","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1073\/pnas.93.11.5472","article-title":"The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease","volume":"93","author":"Mourelatos","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib88","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jnen\/60.4.386","article-title":"Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture","volume":"60","author":"Nagai","year":"2001","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib89","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nn1876","article-title":"Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons","volume":"10","author":"Nagai","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib90","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1083\/jcb.131.6.1715","article-title":"Characterization of a cis-Golgi matrix protein, GM130","volume":"131","author":"Nakamura","year":"1995","journal-title":"J.\u00a0Cell. Biol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib91","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/j.1460-9568.2007.05415.x","article-title":"Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis","volume":"25","author":"Niessen","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib92","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn1971","article-title":"Molecular biology of amyotrophic lateral sclerosis: insights from genetics","volume":"7","author":"Pasinelli","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib93","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ana.410030405","article-title":"Free amino acid levels in amyotrophic lateral sclerosis","volume":"3","author":"Patten","year":"1978","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib94","doi-asserted-by":"crossref","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","article-title":"Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization","volume":"91","author":"Pellerin","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib95","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1113\/jphysiol.2002.035105","article-title":"How to balance the brain energy budget while spending glucose differently","volume":"546","author":"Pellerin","year":"2003","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib96","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00227109","article-title":"Calcitonin gene-related peptide-like immunoreactivity in motoneuron pools innervating different hind limb muscles in the rat","volume":"96","author":"Piehl","year":"1993","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib97","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1212\/WNL.44.10.1933","article-title":"Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in\u00a0vivo","volume":"44","author":"Pioro","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib98","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.410220503","article-title":"Abnormal glutamate metabolism in amyotrophic lateral sclerosis","volume":"22","author":"Plaitakis","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib99","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0166-2236(97)01139-9","article-title":"Reactive astrocytes: cellular and molecular cues to biological function","volume":"20","author":"Ridet","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0006-8993(92)90188-F","article-title":"Spinal dopaminergic system of the rat: light and electron microscopic study using an antiserum against dopamine, with particular emphasis on synaptic incidence","volume":"598","author":"Ridet","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib101","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3171\/jns.1977.47.4.0577","article-title":"Objective clinical assessment of motor function after experimental spinal cord injury in the rat","volume":"47","author":"Rivlin","year":"1977","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib102","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/jnr.10043","article-title":"Lactate reduces glutamate-induced neurotoxicity in rat cortex","volume":"66","author":"Ros","year":"2001","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib103","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1523\/JNEUROSCI.16-07-02335.1996","article-title":"GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn\/pmn mice","volume":"16","author":"Sagot","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib104","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.bjp.0703633","article-title":"An orally active anti-apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease","volume":"131","author":"Sagot","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib105","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1073\/pnas.95.8.4635","article-title":"In\u00a0vivo evidence that erythropoietin protects neurons from ischemic damage","volume":"95","author":"Sakanaka","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib106","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/00207450600754087","article-title":"Serotonergic mechanisms in amyotrophic lateral sclerosis","volume":"116","author":"Sandyk","year":"2006","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib107","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1073\/pnas.92.2.522","article-title":"p115 is a general vesicular transport factor related to the yeast endoplasmic reticulum to Golgi transport factor Uso1p","volume":"92","author":"Sapperstein","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib108","doi-asserted-by":"crossref","first-page":"8779","DOI":"10.1523\/JNEUROSCI.1599-07.2007","article-title":"Progressive motor neuronopathy: a critical role of the tubulin chaperone TBCE in axonal tubulin routing from the Golgi apparatus","volume":"27","author":"Schaefer","year":"2007","journal-title":"J.\u00a0Neurosci."},{"issue":"Suppl.","key":"10.1016\/j.neuropharm.2014.04.009_bib109","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0022-510X(96)00073-1","article-title":"Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis","volume":"139","author":"Schiffer","year":"1996","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/14660820310016822","article-title":"Astrogliosis in ALS: possible interpretations according to pathogenetic hypotheses","volume":"5","author":"Schiffer","year":"2004","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib111","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00005072-199105000-00002","article-title":"A\u00a0new mouse mutant with progressive motor neuronopathy","volume":"50","author":"Schmalbruch","year":"1991","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib112","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/ng1661","article-title":"Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse","volume":"37","author":"Schmitt-John","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib113","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0306-4522(91)90101-S","article-title":"Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies","volume":"45","author":"Simmons","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib114","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.051606598","article-title":"Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress","volume":"98","author":"Siren","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0306-4522(85)90225-8","article-title":"Topographic principles in the spinal projections of serotonergic and non-serotonergic brainstem neurons in the rat","volume":"15","author":"Skagerberg","year":"1985","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib116","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-8993(91)91538-C","article-title":"Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes","volume":"563","author":"Sorg","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib117","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ana.107","article-title":"Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis","volume":"49","author":"Stefan","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib118","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s004010050794","article-title":"The fragmented neuronal Golgi apparatus in amyotrophic lateral sclerosis includes the trans-Golgi-network: functional implications","volume":"95","author":"Stieber","year":"1998","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib119","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-510X(99)00301-9","article-title":"The neuronal Golgi apparatus is fragmented in transgenic mice expressing a mutant human SOD1, but not in mice expressing the human NF-H gene","volume":"173","author":"Stieber","year":"2000","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0304-3940(89)90521-1","article-title":"Calcitonin gene-related peptide increases in rat facial motoneurons after peripheral nerve transection","volume":"101","author":"Streit","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib121","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/WNL.58.5.773","article-title":"Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI","volume":"58","author":"Suhy","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib122","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1083\/jcb.138.4.821","article-title":"Tubulin subunits exist in an activated conformational state generated and maintained by protein cofactors","volume":"138","author":"Tian","year":"1997","journal-title":"J.\u00a0Cell. Biol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib123","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/14660820310009389","article-title":"The serotonin precursor 5-hydroxytryptophan delays neuromuscular disease in murine familial amyotrophic lateral sclerosis","volume":"4","author":"Turner","year":"2003","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib124","first-page":"1099","article-title":"Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study","volume":"254","author":"Unrath","year":"2007","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib125","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nurt.2010.05.012","article-title":"Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes","volume":"7","author":"Vargas","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib126","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/exnr.2001.7797","article-title":"Effect of creatine supplementation on metabolite levels in ALS motor cortices","volume":"172","author":"Vielhaber","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib127","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1083\/jcb.118.5.1015","article-title":"A\u00a0novel 115-kD peripheral membrane protein is required for intercisternal transport in the Golgi stack","volume":"118","author":"Waters","year":"1992","journal-title":"J.\u00a0Cell. Biol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0006-8993(83)91196-4","article-title":"Noradrenergic projections to the spinal cord of the rat","volume":"263","author":"Westlund","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib129","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(96)03181-9","article-title":"Riluzole","volume":"348","author":"Wokke","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2014.04.009_bib130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s12975-011-0120-2","article-title":"Erythropoietin mediates neurobehavioral recovery and neurovascular remodeling following traumatic brain injury in rats by increasing expression of vascular endothelial growth factor","volume":"2","author":"Xiong","year":"2011","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib131","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2005.05.037","article-title":"Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells","volume":"1050","author":"Yamasaki","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib132","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/00004647-199810000-00006","article-title":"Evaluation of a motor deficit after chronic focal cerebral ischemia in rats","volume":"18","author":"Yonemori","year":"1998","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib133","first-page":"73","article-title":"Spinal muscular atrophy: from animal model to clinical trial","volume":"25","author":"Zanoteli","year":"2010","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib134","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jocn.2009.08.014","article-title":"Erythropoietin enhances survival of facial motor neurons by inhibiting expression of inducible nitric oxide synthase after axotomy","volume":"17","author":"Zhang","year":"2010","journal-title":"J.\u00a0Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.04.009_bib135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(92)91442-H","article-title":"Decreased immunoreactive (IR) calcitonin gene-related peptide correlates with sprouting of IR-peptidergic and serotonergic neuronal processes in spinal cord and brain nuclei from the Wobbler mouse during motoneuron disease","volume":"587","author":"Zhang","year":"1992","journal-title":"Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081400135X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081400135X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T14:52:39Z","timestamp":1746197559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081400135X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":135,"alternative-id":["S002839081400135X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.04.009","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurodegenerative changes are prevented by Erythropoietin in the pmn model of motoneuron degeneration","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}